A director at Agfa-Gevaert NV bought 80,000 shares at 0.681EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Agfa-Geveart: Material miss on Healthcare activities. ASML: Long-term guidance confirmed. CVC Capital Partners: Comfortably on track. DEME Group: Raises outlook, lowers capex guidance. Proximus: Pressure on CEO from another possible coalition party. SBM Offshore: Again delivering
3Q24 numbers were below our and CSS forecasts. We will update our model but we already lower our Target Price from € 2.0 to € 1.4. 3Q24 sales came in at € 277m (KBCSe € 291, CSS 286) and 3Q24 REBIT was €4m (KBCSe € 8.1m, CSS € 7m) with especially a poor performance in Radiology Solutions. Agfa hinted at a strong profitability step up in Digital Printing and Chemicals, and a significant increase in order intake in HealthCare IT, with a high share of cloud-based and net new customer contracts. Thi...
The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro - regulated information Regulated information November 14, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro The Agfa-Gevaert Group posted double-digit revenue growth and a strong profitability step up in Digital Printing and Chemicals, and a significant increase in order intake in HealthCare IT, with a high share of cloud-based and net new customer contracts. This was counterbalanced by an accelerated m...
De Agfa-Gevaert Groep in het derde kwartaal van 2024: stabiele omzet, aangepaste EBITDA van 15 miljoen euro - gereglementeerde informatie Gereglementeerde informatie 14-11-2024 - 7:45 uur CET De Agfa-Gevaert Groep in het derde kwartaal van 2024: stabiele omzet, aangepaste EBITDA van 15 miljoen euro De Agfa-Gevaert Groep noteerde een omzetgroei met dubbele cijfers en een sterke rendabiliteitsverbetering in Digital Printing and Chemicals, alsook een aanzienlijke toename van de order intake in HealthCare IT, met een groo...
Agfa kondigt plan aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt - gereglementeerde informatie 14 november 2024 – 7:45 uur CET Gereglementeerde informatie Agfa kondigt plan aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt Mortsel, België – 14 november 2024 – 7u45 Agfa kondigde vandaag een plan aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt. De onderneming heeft de intentie om alle aspecten van de filmgerelateerde...
Agfa announces plan to adjust the cost base of its traditional film activities to the reality in the market - regulated information November 14, 2024 – 7:45 a.m. CET Regulated information Agfa announces plan to adjust the cost base of its traditional film activities to the reality in the market Mortsel, Belgium – November 14, 2024 – 7:45 a.m. CET Agfa today announced a plan to adjust the cost base of its traditional film activities to the reality in the market. The company has the intention to thoroughly reorganize all aspects of the film-related...
Publication of a transparency notification – Regulated information Publication of a transparency notification – Regulated information(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium – November 4, 2024 – 5:45 p.m. CET According to Agfa-Gevaert NV’s bylaws, the threshold as from which a shareholding needs to be disclosed, has been set at 3%, 5% and a multiple of 5%. In conformity with the Law of May 2, 2007 regarding the disclosure of significant sharehold...
Publication of a transparency notification – Regulated information Publication of a transparency notification – Regulated information(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium – October 14, 2024 – 5:45 p.m. CET According to Agfa-Gevaert NV’s bylaws, the threshold as from which a shareholding needs to be disclosed, has been set at 3%, 5% and a multiple of 5%. In conformity with the Law of May 2, 2007 regarding the disclosure of significant shareholdings in listed companies, Agfa-Gevaert (Eur...
Fiona Lam appointed as CFO for the Agfa-Gevaert Group - Regulated information - Contains inside information October 14, 2024 - 7:45 a.m. CET Regulated information - Contains inside information Fiona Lam appointed as CFO for the Agfa-Gevaert Group Mortsel, Belgium – October 14, 2024 – 7:45 a.m. CET On October 15, 2024, Fiona Lam joins the Agfa-Gevaert Group as Chief Financial Officer and member of the Executive Committee. Current CFO Dirk De Man has decided to take a step back due to health reasons. CEO Pascal Juéry commented: “I am deli...
Following Agfa-Gevaert's 2Q24 results we reiterate our HOLD and cut our target price from €1.6 to €1.2. We still struggle to see a clear and sustainable path for profitability and FCF generation in the short term, arguing that several restructuring initiatives must be successfully implemented before this can happen. We see the potential closing of the divestment of Offset Solutions as well as the continued growth of Zirfon as two key positives for the longer term. We believe all this is already ...
Following a seasonally weaker 1Q24, 2Q24 revenues remained stable at 286m (beating our €270 and CSS € 285m) based on the resurgence of sales for the Digital Printing Solutions growth engine. Agfa indicated that the Green Hydrogen Solutions business continued its top line growth, while HealthCare IT sales started to pick up following the weak first quarter. The traditional film activities continued to be under pressure from the weakness in the electronics market and the new central procurement pr...
The Agfa-Gevaert Group in Q2 2024: solid quarter, powered by growth engines - regulated information - inside information Regulated information – Inside information August 28, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in Q2 2024: solid quarter, powered by growth engines HealthCare IT: Highest ever quarterly order intake recorded: 22% increase in the 12 months rolling order intake versus the year before, mainly based on cloud-related contracts Digital Print & Chemicals: Continuous double digit growth for Green Hydrogen SolutionsDigital...
De Agfa-Gevaert Groep in het tweede kwartaal van 2024: degelijk kwartaal, aangedreven door de groeimotoren - gereglementeerde informatie - voorkennis Gereglementeerde informatie – Voorwetenschap 28-08-2024 - 7:45 uur CET De Agfa-Gevaert Groep in het tweede kwartaal van 2024: degelijk kwartaal, aangedreven door de groeimotoren HealthCare IT: Hoogste order intake ooit per kwartaal: 22% stijging in 12 maanden lopende order intake tegenover het voorgaande jaar, vooral op basis van cloud-contracten Digital Print & Chemi...
A director at Crescent NV bought 23,809,524 shares at 0.010EUR and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.